JPRN-UMIN000010850招募中未知
Japan registry to use of Promus element in acute coronary syndrome patients - J-POSEIDON registry
Society of ACS Intervention and Therapeutics0 个研究点目标入组 500 人开始时间: 2013年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •F)Enrolled in another study (excluding PMS) or receiving any treatment affected the registry. G)Pregnant or possibility of pregnancy in the registry period. H)Known hypersensitivity reaction to everolimus, polymer, metal I)Known hypersensitivity reaction to antiplatelet J)Improper functioning of the liver K)Kidney malfunction(>=3.0mg/dl serum creatinine level) or dialysis treatment. L)Active cancer M)Lesion in saphenous vein graft N)cardiogenic shock by clinical assessment
研究者
相似试验
尚未招募
Unknown
Japanese registry of primary prevention implantable cardioverter defibrillator in heart failure patientsHeart failure patients with primary prevention implantable cardioverter defibrillatorJPRN-UMIN000051757Tokyo Women's Medical University1,500
已完成
不适用
Japan Prosthetic Valve Registrypost prosthetic valve replacementJPRN-UMIN000013617Academic committee of Japanese society of Echocardiography300
招募中
不适用
Japan Apheresis RegistryAny Conditions Requiring Therapeutic ApheresisJPRN-UMIN000039498Japanese Society for Apheresis10,000
已完成
3 期
Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional DyspepsiaDyspepsiaNCT00112203Forest Laboratories466
招募中
不适用
J-REGISTER: Japanese REal-world data for treatment of afatinib (GIotrif) in first-line setting and Subsequent Therapies for patients with advanced EGFR mutation-positive lung adenocarcinomaJPRN-UMIN000044071ippon Boehringer Ingelheim Co., Ltd.1,000
